IKur/Kv1.5 channel blockers for the treatment of atrial fibrillation

Characterization of Human Cardiac Kv1.5 Inhibition by the Novel Atrial-selective Antiarrhythmic Compound AVE1231

(2009) Joachim R Ehrlich et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Vernakalant in the Management of Atrial Fibrillation

(2008) Judy WM Cheng   ANNALS OF PHARMACOTHERAPY

Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation

(2008) Denis Roy et al.   CIRCULATION

Acacetin, a Natural Flavone, Selectively Inhibits Human Atrial Repolarization Potassium Currents and Prevents Atrial Fibrillation in Dogs

(2008) Gui-Rong Li et al.   CIRCULATION

Vernakalant – a promising therapy for conversion of recent-onset atrial fibrillation

(2008) Gerald V Naccarelli et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Can inhibition of IKur promote atrial fibrillation?

(2008) Alexander Burashnikov et al.   HEART RHYTHM

Atrial-Selective Sodium Channel Blockers: Do They Exist?

(2008) Alexander Burashnikov et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

New Drugs Targeting the Cardiac Ultra-Rapid Delayed-Rectifier Current (IKur): Rationale, Pharmacology and Evidence for Potential Therapeutic Value

(2008) John W Ford et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure

(2008) Denis Roy et al.   NEW ENGLAND JOURNAL OF MEDICINE